Less Ads, More Data, More Tools Register for FREE

Pin to quick picksColefax Grp. Regulatory News (CFX)

Share Price Information for Colefax Grp. (CFX)

Share Price is delayed by 15 minutes
Get Live Data
1,400.00    5.00 (0.36%)
Bid:
1,380.00
Ask:
1,420.00
Spread: 40.00 (2.899%)
Market Cap: £72.32m
CFX Live PriceLast checked at - London Stock Exchange

Intraday Colefax Grp. Share Chart

Share Buyback Launch

28 May 2026 07:00

RNS Number : 9495F
Colefax Group PLC
28 May 2026
 

AIM: CFX

COLEFAX GROUP PLC

("Colefax" or the "Company")

Launch of Share Buyback via Reverse Bookbuild

 

The Company today announces a share buyback to purchase ordinary shares of 10.0 pence each in the Company ("Ordinary Shares") for a maximum consideration of up to £2,546,765.00 via a reverse bookbuild (the "Buyback").

 

The Company has for a number of years followed a policy of buying back Ordinary Shares in order to enhance earnings for the remaining shareholders. Pursuant to this policy, the Company has previously launched a number of tender offers to buy back Ordinary Shares, the most recent being in October 2025 (the "2025 Tender Offer"). Due to the limited remaining authority to buy back Shares granted at the Company's 2025 Annual General Meeting held on 22 September 2025, the directors considered it appropriate to launch the current Buyback, which is expected to save time and costs and provide shareholders with an opportunity to sell their Ordinary Shares without incurring the costs involved in a formal tender offer.

 

The Company has engaged Peel Hunt LLP ("Peel Hunt") to implement the Buyback. Pursuant to the Buyback, Peel Hunt will purchase, as principal, up to a maximum of 195,905 Ordinary Shares (being c. 3.7 per cent. of the Company's Ordinary Shares) at a price of £13.00 per Ordinary Share (the "Purchase Price"). The Company has granted a put option to Peel Hunt pursuant to a repurchase agreement (the "Repurchase Agreement") under which Peel Hunt may require the Company to purchase at the Purchase Price the Ordinary Shares purchased by Peel Hunt pursuant to the Buyback. The Buyback is subject to the conditions set out in the Repurchase Agreement being fulfilled.

 

The reverse bookbuild will commence immediately following this announcement and will be closed at 16:35 (BST) on 01 June 2026. The final number of shares to be purchased will be agreed at the close of the reverse bookbuild at the sole discretion of Colefax and Peel Hunt, and the results of the reverse bookbuild will be announced as soon as practicable thereafter. To the extent that the reverse bookbuild is oversubscribed, orders will be scaled back (whether on a pro rata basis or otherwise) at the sole discretion of Colefax and Peel Hunt.

 

CREST Shareholders wishing to sell Ordinary Shares as part of the Buyback should inform their broker to contact Peel Hunt before 16:35 (BST) on 01 June 2026.

 

Certificated shareholders wishing to sell Ordinary Shares as part of the Buyback should e-mail colefaxbuyback@computershare.co.uk to receive a Share Buyback form. The completed form and copy of the relevant certificate should be emailed back to Computershare using the same email address. These are to be received no later than 15:00 (BST) on 01 June 2026.

 

Purchase of the Company's Ordinary Shares pursuant to the Buyback will take place following announcement of the result of the reverse bookbuild.

 

The primary purpose of the Buyback is to reduce the share capital of the Company. The Ordinary Shares purchased under the Buyback will be cancelled.

 

The directors of the Company consider the Buyback to be in the best interests of the Company and of its shareholders generally, with the implementation of the Buyback expected to enhance earnings per share.

 

Any purchase of Ordinary Shares under the Buyback will be carried out on the London Stock Exchange and shall take place in accordance with (and subject to the limits prescribed by) the Company's general authority to repurchase Ordinary Shares granted by its shareholders at the annual general meeting on 22 September 2025 (the "2025 Authority"). Details of the 2025 Authority can be found on page 56 of the 2025 Annual Report which can be viewed on the Company's website at colefaxgroupplc.com. After the 2025 Tender Offer, the remaining maximum number of Ordinary Shares that the Company is authorised to purchase under the 2025 Authority is 195,905.

 

The person responsible for arranging the release of this announcement on behalf of the Company is

Robert Barker, the Group Finance Director and Company Secretary.

 

Enquiries:

 

Colefax Group plc

David Green, Chief Executive

Rob Barker, Finance Director

 

+44 (0)20 7318 6000

Peel Hunt LLP (NOMAD and broker)

Dan Webster

Andrew Clark

Finn Nugent

Sohail Akbar (ECM)

 

+44 (0)20 7418 8900

KTZ Communications

Katie Tzouliadis

Robert Morton

+44 (0)20 3178 6378

 

Important Notices

 

Peel Hunt LLP ("Peel Hunt"), which is authorised and regulated in the United Kingdom by the FCA, is acting as nominated adviser and broker exclusively for Colefax and no one else in connection with the matters set out in this announcement and will not regard any other person as its client in relation to the matters set out in this announcement and will not be responsible to anyone other than Colefax for providing the protections afforded to clients of Peel Hunt, nor for providing advice in relation to the contents of this announcement or any other matter referred to herein. Neither Peel Hunt nor any of its subsidiaries, branches or affiliates owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Peel Hunt in connection with this announcement, any statement contained herein or otherwise or any transaction, arrangement or other matter referred to herein.

 

Neither Peel Hunt nor any of its affiliates nor any of their respective directors, officers, employees, advisers or agents accepts any responsibility or liability whatsoever for, or makes any representation or warranty, express or implied, as to, the truth, accuracy or completeness of the information in this announcement (or whether any information has been omitted from the announcement) or any other information relating to Colefax, whether written, oral or in a visual or electronic form, and howsoever transmitted or made available or for any loss howsoever arising from any use of this announcement or its contents or otherwise arising in connection therewith.

 

All times referred to are London, UK, time unless otherwise stated.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCZZGZKVNLGVZM
Date   Source Headline
2nd Jun 20267:00 amRNSResult of Share Buyback and TVR
28th May 20267:00 amRNSShare Buyback Launch
8th May 20267:00 amRNSFull Year Trading Update
10th Feb 20261:37 pmRNSTR-1 Notification
28th Jan 20267:00 amRNSHalf Year Results
30th Oct 20253:52 pmRNSTR-1 Notification
30th Oct 20253:38 pmRNSTR-1 Notification
30th Oct 20253:25 pmRNSTR-1 Notification
29th Oct 20251:59 pmRNSTR-1 Notification
28th Oct 20257:01 amRNSDirector/PDMR Shareholding
28th Oct 20257:00 amRNSResult of Tender Offer, Purchase of Own Shares,TVR
13th Oct 20257:00 amRNSTender Offer
8th Oct 20251:03 pmRNSHolding(s) in Company
22nd Sep 20252:17 pmRNSResult of AGM
22nd Sep 20257:00 amRNSAGM Statement
9th Sep 20252:28 pmRNSNotification of Transactions of Director
29th Jul 20257:00 amRNSPreliminary Results
3rd Feb 202512:48 pmRNSHolding(s) in Company
22nd Jan 20257:00 amRNSHalf-year Results
27th Nov 20247:00 amRNSBoard Appointment
25th Oct 202412:16 pmRNSHolding(s) in Company
25th Oct 202411:18 amRNSDirector/PDMR Share Dealings
25th Oct 202411:08 amRNSHolding(s) in Company
24th Oct 20247:00 amRNSResult of Share Buyback
22nd Oct 20247:00 amRNSLaunch of Share Buyback Programme
26th Sep 20243:06 pmRNSResult of AGM
26th Sep 20247:00 amRNSAGM Statement
31st Jul 20247:00 amRNSPreliminary Results
21st Mar 20247:00 amRNSDirector/PDMR Shareholding
30th Jan 20247:00 amRNSInterim Results
2nd Oct 20235:41 pmRNSHolding(s) in Company
28th Sep 20232:59 pmRNSResult of AGM
28th Sep 20237:00 amRNSAGM Statement
25th Sep 20237:00 amRNSDirector/PDMR Shareholding
22nd Sep 20237:00 amRNSResult of Tender Offer
1st Sep 20237:00 amRNSTender Offer
23rd Jan 20237:00 amRNSInterim Results
20th Dec 20223:27 pmRNSHolding(s) in Company
19th Oct 20225:21 pmRNSDirector/PDMR Shareholding
5th Oct 20224:55 pmRNSHolding(s) in Company
29th Sep 20223:22 pmRNSResult of AGM
29th Sep 20222:46 pmRNSHolding(s) in Company
29th Sep 20227:00 amRNSAGM Statement
26th Sep 20223:54 pmRNSHolding(s) in Company
26th Sep 20227:00 amRNSTransaction in Own Shares
23rd Sep 20227:00 amRNSLaunch of Share Buyback Programme
23rd Sep 20227:00 amRNSLaunch of Share Buyback Programme
17th Aug 20227:00 amRNSPreliminary Results
21st Apr 20227:00 amRNSTrading Update
27th Jan 20227:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.